Who is sponsoring NCT04763304?

NCT04763304 is sponsored by Hospital Italiano de Buenos Aires.

What drugs are being tested in NCT04763304?

Interventions in NCT04763304: Gown personal protective equipment (PPE-G) suit, Coverall personal protective equipment (PPE-C) suit.

What condition does NCT04763304 study?

NCT04763304 studies Personal Protective Equipment, Self Contamination.

Is NCT04763304 still recruiting?

NCT04763304 is currently completed. Last updated 21 February 2021.

Last reviewed 2021-02-21 · How we verify

NCT04763304

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial

Completed NA Last updated 21 February 2021

What this trial tests

NA trial testing Gown personal protective equipment (PPE-G) suit in Personal Protective Equipment in 60 participants. Completed in 18 November 2020.

Timeline

1 September 2020

Primary endpoint
29 October 2020

18 November 2020

Quick facts

Lead sponsor	Hospital Italiano de Buenos Aires
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	60
Start date	1 September 2020
Primary completion	29 October 2020
Estimated completion	18 November 2020
Sites	1 location across Argentina

Drugs / interventions tested

Gown personal protective equipment (PPE-G) suit
Coverall personal protective equipment (PPE-C) suit

Conditions studied

Personal Protective Equipment — all drugs for Personal Protective Equipment →
Self Contamination — all drugs for Self Contamination →

Sponsor

Hospital Italiano de Buenos Aires

Who can join

18 and older, any sex, with Personal Protective Equipment or Self Contamination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anesthesiologists and other professionals are at high risk of viral infection during aerosol-generating procedures. Knowledge of the protective quality of PPE suits and the risk of self-contamination after removal is paramount. This trial used an ultraviolet-fluorescent solution to explore differences in self-contamination after removal of gown PPE (PPE-G) and coverall PPE (PPE-C). A two-period/two-intervention (AB/BA) design was chosen; each intervention consisted of audio-guided placement of PPE, full-body spraying of fluorescent solution, audio-guided removal of PPE, and assessment of self-contamination through ultraviolet light scanning. The primary outcome was the mean within-participant difference (traces of any size) between PPE suits. Statistical significance was tested using t test for paired data.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Self-contamination following removal of two personal protective equipment suits: a randomized, controlled, crossover simulation trial.
Sanchez Novas D, Fernández MS, García Guzzo ME, Aguilar Avila LT, et al · · 2022 · cited 3× · PMID 34606932 · DOI 10.1016/j.jhin.2021.09.017

Verify or expand the search:

Other Hospital Italiano de Buenos Aires trials

Trials by the same sponsor.

NCT07397416 — Impact of Implementing a Rapid PCR-based Algorithm for Carbapenemase-producing Enterobacterales (CPE) and Infection Cont · NA · not yet recruiting
NCT07167173 — Predictive Model for Multidrug Resistance in Patients Admitted to the Emergency Department With Sepsis · not yet recruiting
NCT06683781 — Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients · recruiting
NCT06573723 — Institutional Registry of Rare Diseases · recruiting
NCT06609798 — Ultrasound Assessment During Weaning from Mechanical Ventilation · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04763304 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Italiano de Buenos Aires
Last refreshed: 21 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04763304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing